InsidersTradesSigma
Total declarations
Company
▲ Purchases (4 ops.)
▼ Sales (0 ops.)
Explore the detailed record of transactions filed by Cohen Neil Harris, Director. Director active across 1 companies, notably Chemomab Therapeutics Ltd.. In total, 4 reports have been recorded. Total volume traded: €40k. The latest transaction was disclosed on 18 May 2022 (Acquisition). Regulator: SEC (Form 4). All data is free.
Declarations4 total
€6,0922,000 shares@ €3.0460.051% mcap15.2% of flow
American Depositary Shares
SEC:0001178913-22-002093:0·
Ideal exit: 12 Feb 2023 (T+270)
€7,6842,000 shares@ €3.84190.065% mcap19.2% of flow
American Depositary Shares
SEC:0001178913-22-001117:0·
Ideal exit: 9 Dec 2022 (T+270)
€13,1452,000 shares@ €6.5724100.0% of flow
American Depositary Shares
SEC:0001178913-21-003807·
Ideal exit: 2 Sept 2022 (T+270)
€13,1452,000 shares@ €6.57240.11% mcap32.8% of flow
American Depositary Shares
SEC:0001178913-21-003807:0·
Ideal exit: 2 Sept 2022 (T+270)
4 of 4 declarations
About Cohen Neil Harris
Neil Harris Cohen is a Director of Chemomab Therapeutics Ltd. In this role, he participates in the governance of the company and strategic decision-making. His experience in the biopharmaceutical sector is an asset for the organization.
